Shepherd Kaplan Krochuk, LLC Novartis Ag Transaction History
Shepherd Kaplan Krochuk, LLC
- $127 Million
- Q3 2024
A detailed history of Shepherd Kaplan Krochuk, LLC transactions in Novartis Ag stock. As of the latest transaction made, Shepherd Kaplan Krochuk, LLC holds 10,000 shares of NVS stock, worth $970,800. This represents 0.49% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$970,800% of portfolio
0.49%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$786 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$678 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$560 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...